Fig. 2
From: Cerumenogram as an assay for the metabolic diagnosis of precancer, cancer, and cancer remission
(A) Cerumenogram protocol for the volunteer. (B) The volunteer’s oncological 18F-FDG PET/CT exam indicated a hypermetabolic region in the zygomaticus minor and major muscles with an SUVmax of 6.9 g mL−1.
